UltraSight
7
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI
Role: collaborator
ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access
Role: lead
Automated Ultrasound Cardiac Guidance Tool
Role: lead
Human Factors Study of Ultrasound Navigation Software for Cardiac Imaging
Role: lead
Study for the Assessment of the Quality of Echocardiographic Clips.
Role: lead
Optimization of an Automated Ultrasound Cardiac Guidance Tool
Role: lead
Study for the Assessment of USEG Software.
Role: lead
All 7 trials loaded